Introduction
Unnati Pharmax is committed to delivering high-quality pharmaceutical products that meet global standards of safety, quality, and efficacy. Our oncology-focused portfolio includes a wide range of Abiraterone Acetate tablets, developed to support healthcare professionals in the management of advanced prostate cancer under prescribed medical supervision. With a strong emphasis on quality manufacturing and regulatory compliance, Unnati Pharmax offers multiple strengths and brand options to meet diverse market requirements.
Understanding Abiraterone Acetate
Abiraterone Acetate is widely used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC), as prescribed by healthcare professionals. It works by inhibiting androgen production, which plays a key role in the progression of prostate cancer.
Unnati Pharmax ensures that all Abiraterone products are manufactured following stringent quality control processes to ensure consistency, purity, and reliability.
Our Abiraterone Product Range
ABIRANAMO 250 MG & ABIRANAMO 500 MG
ABIRANAMO is a trusted Abiraterone Acetate formulation available in both 250 mg and 500 mg strengths. It is designed to meet international quality benchmarks and is suitable for regulated and semi-regulated markets.
Key Features:
High-quality Abiraterone Acetate formulation
Available in two strengths for dosing flexibility
Manufactured under GMP-compliant facilities
XBIRA 250 MG & XBIRA 500 MG
XBIRA tablets are developed with a focus on consistent bioavailability and stability. These products are widely accepted across multiple markets due to their reliable quality profile.
Key Features:
Available in 250 mg and 500 mg strengths
Stringent in-process quality checks
Suitable for long-term oncology treatment protocols
ABIRAPRO 250 MG
ABIRAPRO 250 MG is a precisely formulated Abiraterone Acetate tablet designed for optimal performance and quality assurance.
Key Features:
Accurate dosage strength
Stable formulation
Ideal for institutional and export supply
ABIRAKAST
ABIRAKAST is part of Unnati Pharmax’s specialized oncology portfolio. It is formulated to maintain consistency and compliance with global pharmaceutical standards.
Key Features:
Reliable formulation
Produced under strict quality systems
Export-oriented product
BDRON 250 MG & BDRON 500 MG
BDRON tablets are manufactured using high-grade raw materials and advanced processing techniques to ensure product reliability.
Key Features:
Available in 250 mg and 500 mg
Consistent batch-to-batch quality
Designed for international supply chains
MYTERA 250 MG & MYTERA 500 MG
MYTERA is a well-positioned Abiraterone brand in Unnati Pharmax’s oncology segment, known for its formulation precision.
Key Features:
Two strength options: 250 mg and 500 mg
Focus on stability and shelf life
Manufactured under GMP guidelines
AHABIR 250 MG & AHABIR 500 MG
AHABIR tablets are designed to meet the needs of healthcare providers seeking consistent and dependable Abiraterone formulations.
Key Features:
Available in both 250 mg and 500 mg strengths
High manufacturing standards
Suitable for global distribution
AB-Tyra 250 MG & AB-Tyra 500 MG
AB-Tyra is a high-quality Abiraterone Acetate product developed to support oncology treatment regimens as prescribed.
Key Features:
Available in 250 mg and 500 mg
Robust quality control
Export-ready packaging options
Why Choose Unnati Pharmax?
GMP-Compliant Manufacturing: Ensuring quality, safety, and consistency
Wide Product Portfolio: Multiple brands and strengths of Abiraterone Acetate
Global Market Focus: Products designed for domestic and international markets
Quality Assurance: Strict testing at every stage of production
Conclusion
Unnati Pharmax’s comprehensive range of Abiraterone Acetate tablets—including ABIRANAMO, XBIRA, ABIRAPRO, ABIRAKAST, BDRON, MYTERA, AHABIR, and AB-Tyra—reflects our commitment to quality-driven pharmaceutical manufacturing. Our products are developed to meet global standards and support healthcare systems worldwide.
For partnership opportunities, product inquiries, or export-related information, connect with Unnati Pharmax and explore reliable oncology solutions built on trust and quality.
